-
1
-
-
68449084678
-
Metastatic breast cancer: Therapeutic options according to molecular subtypes and prior adjuvant therapy
-
Guarneri V, Conte P. Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist 2009; 14(7): 645-656.
-
(2009)
Oncologist
, vol.14
, Issue.7
, pp. 645-656
-
-
Guarneri, V.1
Conte, P.2
-
2
-
-
10444284584
-
-
54th edition, Megestrol acetate British Medical Association and Royal Pharmaceutical Society of Great Britain
-
British National Formulary (54th edition, 2007). Megestrol acetate British Medical Association and Royal Pharmaceutical Society of Great Britain.
-
(2007)
British National Formulary
-
-
-
3
-
-
0023914450
-
An overview of megestrol acetate for the treatment of advanced breast cancer
-
Sedlacek SM. An overview of megestrol acetate for the treatment of advanced breast cancer. Semin Oncol 1988; 15 (2 Suppl 1): 3-13.
-
(1988)
Semin Oncol
, vol.15
, Issue.2 SUPPL. 1
, pp. 3-13
-
-
Sedlacek, S.M.1
-
4
-
-
0030845035
-
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor- Positive metastatic breast cancer: A southwest oncology group phase III trial
-
Russel CA, Green SJ, O'Sullivan J, Hynes HE, Budd GT, Congdon JE et al. Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial. J Clin Oncol 1997; 15 (7): 2494-2501. (Pubitemid 27289877)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.7
, pp. 2494-2501
-
-
Russell, C.A.1
Green, S.J.2
O'Sullivan, J.3
Hynes, H.E.4
Budd, G.T.5
Congdon, J.E.6
Martino, S.7
Osborne, C.K.8
-
5
-
-
0027103824
-
Second and third line hormonotherapy in advanced post-menopausal breast cancer: A multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen
-
Garcia-Giralt E, Ayme Y, Carton M, Daban A, Delozier T, Fargeot P et al. Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifene. Breast Cancer Res Treat 1992; 24 (2): 139-145. (Pubitemid 23063896)
-
(1992)
Breast Cancer Research and Treatment
, vol.24
, Issue.2
, pp. 139-145
-
-
Garcia-Giralt, E.1
Ayme, Y.2
Carton, M.3
Daban, A.4
Delozier, T.5
Fargeot, P.6
Fumoleau, P.7
Gorins, A.8
Guerin, D.9
Guerin, R.10
Maillart, P.11
Mauriac, L.12
May-Levin, F.13
Metz, R.14
Namer, M.15
Olivier, J.P.16
Pommatau, E.17
Pouillart, P.18
Pujade-Lauraine, E.19
-
6
-
-
61449477568
-
Maintenance treatment in metastatic breast cancer
-
Sànchez-Munoz A, Perez-Ruiz E, Ribelles N, Marquez A, Alba E. Maintenance treatment in metastatic breast cancer. Expert Rev Anticancer Ther 2008; 8 (12): 1907-1912.
-
(2008)
Expert Rev Anticancer Ther
, vol.8
, Issue.12
, pp. 1907-1912
-
-
Sànchez-Munoz, A.1
Perez-Ruiz, E.2
Ribelles, N.3
Marquez, A.4
Alba, E.5
-
7
-
-
12944279734
-
Metronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer
-
DOI 10.1046/j.1439-0353.2005.04048.x
-
Gille J, Spieth K, Kaufmann R. Metronomic low-dose chemotherapy as antiangiogenetic therapeutic strategy for cancer. J Dtsch Dermatol Ges 2005; 3 (1): 26-32. (Pubitemid 40175154)
-
(2005)
JDDG - Journal of the German Society of Dermatology
, vol.3
, Issue.1
, pp. 26-32
-
-
Gille, J.1
Spieth, K.2
Kaufmann, R.3
-
8
-
-
0035214416
-
Metronomic scheduling: The future of chemotherapy?
-
Gasparini G. Metronomic scheduling: the future of chemotherapy? Lancet Oncol 2001; 2 (12): 733-740.
-
(2001)
Lancet Oncol
, vol.2
, Issue.12
, pp. 733-740
-
-
Gasparini, G.1
-
10
-
-
3242678017
-
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy
-
Drevs J, Fakler J, Eisele S, Medinger M, Bing G, Esser N et al. Antiangiogenetic potency of various chemotherapeutic drugs for metronomic chemotherapy. Anticancer Res 2004; 24 (3a): 1759-1763. (Pubitemid 38954706)
-
(2004)
Anticancer Research
, vol.24
, Issue.3 A
, pp. 1759-1763
-
-
Drevs, J.1
Fakler, J.2
Eisele, S.3
Medinger, M.4
Bing, G.5
Esser, N.6
Marme, D.7
Unger, C.8
-
11
-
-
0035135813
-
Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study
-
DOI 10.1023/A:1008334227668
-
Nolè F, Munzone E, Mandalà M, Catania C, Orlando L, Zampino MG et al. Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study. Ann Oncol 2001; 12 (1): 95-100. (Pubitemid 32162453)
-
(2001)
Annals of Oncology
, vol.12
, Issue.1
, pp. 95-100
-
-
Nole, F.1
Munzone, E.2
Mandala, M.3
Catania, C.4
Orlando, L.5
Zampino, M.G.6
Minchella, I.7
Colleoni, M.8
Peruzzotti, G.9
Marrocco, E.10
Goldhirsch, A.11
-
12
-
-
33750693021
-
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients
-
Correale P, Cerretani D, Remondo C, Martellucci I, Marsili S, La Placa M et al. A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients. Oncol Rep 2006; 16(1): 133-140.
-
(2006)
Oncol Rep
, vol.16
, Issue.1
, pp. 133-140
-
-
Correale, P.1
Cerretani, D.2
Remondo, C.3
Martellucci, I.4
Marsili, S.5
La Placa, M.6
-
13
-
-
33846515135
-
Weekly Docetaxel and Epirubicin in Treatment of Advanced Hormone-Refractory Prostate Cancer
-
DOI 10.1016/j.urology.2006.09.015, PII S0090429506021376
-
Petrioli R, Paolelli L, Francini E, Manganelli A, Salvestrini F, Francini G. Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer. Urology 2007; 69 (1): 142-146. (Pubitemid 46161681)
-
(2007)
Urology
, vol.69
, Issue.1
, pp. 142-146
-
-
Petrioli, R.1
Paolelli, L.2
Francini, E.3
Manganelli, A.4
Salvestrini, F.5
Francini, G.6
-
14
-
-
0035049886
-
Chemotherapy of metastatic breast cancer: What to expect in 2001 and beyond
-
DOI 10.1634/theoncologist.6-2-133
-
Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN. Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 2001; 6 (2): 133-146. (Pubitemid 32323452)
-
(2001)
Oncologist
, vol.6
, Issue.2
, pp. 133-146
-
-
Esteva, F.J.1
Valero, V.2
Pusztai, L.3
Boehnke-Michaud, L.4
Buzdar, A.U.5
Hortobagyi, G.N.6
-
15
-
-
0036392350
-
Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens
-
Francini G, Petrioli R, Messinese S, Pozzessere D, Marsili S, Correale P et al. Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens. Cancer Chemother Pharmacol 2002; 50 (4): 271-276.
-
(2002)
Cancer Chemother Pharmacol
, vol.50
, Issue.4
, pp. 271-276
-
-
Francini, G.1
Petrioli, R.2
Messinese, S.3
Pozzessere, D.4
Marsili, S.5
Correale, P.6
-
16
-
-
33645992772
-
Third-line hormonal treatment with exemestane in post-menopausal patients with advanced breast cancer progressing on letrazole or anastrazole. A phase II trial conducted by the Ellenic group of oncology (HELGO)
-
Gennatas C, Michalaki V, Carvounis E, Psychogios J, Poulakaki N, Katsiamis G et al. Third-line hormonal treatment with exemestane in post-menopausal patients with advanced breast cancer progressing on letrazole or anastrazole. A phase II trial conducted by the Ellenic group of oncology (HELGO). Tumori 2006; 92 (1): 13-17.
-
(2006)
Tumori
, vol.92
, Issue.1
, pp. 13-17
-
-
Gennatas, C.1
Michalaki, V.2
Carvounis, E.3
Psychogios, J.4
Poulakaki, N.5
Katsiamis, G.6
-
17
-
-
0036373257
-
Monotherapy with paclitaxel as third-line chemotherapy against anthracycline-pretreated and docetaxel-refractory metastatic breast cancer
-
Kinoshita J, Haga S, Shimizu T, Imamura H, Watanabe O, Nagumo H et al. Monotherapy with paclitaxel as third-line chemotherapy against anthracycline-pretreated and docetaxel-refractory metastatic breast cancer. Breast Cancer 2002: 9 (2): 166-169.
-
(2002)
Breast Cancer
, vol.9
, Issue.2
, pp. 166-169
-
-
Kinoshita, J.1
Haga, S.2
Shimizu, T.3
Imamura, H.4
Watanabe, O.5
Nagumo, H.6
-
18
-
-
0028812586
-
Cisplatin and VP16 in metastatic breast carcinoma as a third-line chemotherapy: A randomized study comparing low versus high doses of cisplatin
-
Ceci G, Bisagni G, Cocconi G, Rodinò C, Belsanti V, Bertusi M et al. Cisplatin and VP16 in metastatic breast carcinoma as a third-line chemotherapy: a randomized study comparing low versus high doses of cisplatin. Tumori 1995; 81 (4): 241-244.
-
(1995)
Tumori
, vol.81
, Issue.4
, pp. 241-244
-
-
Ceci, G.1
Bisagni, G.2
Cocconi, G.3
Rodinò, C.4
Belsanti, V.5
Bertusi, M.6
-
19
-
-
21844436308
-
Megestrol acetate for the treatment of anorexia-cachexia syndrome
-
CD004310
-
Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2005 (2): CD004310.
-
(2005)
Cochrane Database Syst Rev
, Issue.2
-
-
Berenstein, E.G.1
Ortiz, Z.2
-
20
-
-
0028257911
-
Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide
-
Brufman G, Isacson R, Haim N, Gez E, Sulkes A. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide. Oncology 1994; 51(3): 258-261. (Pubitemid 24113209)
-
(1994)
Oncology
, vol.51
, Issue.3
, pp. 258-261
-
-
Brufman, G.1
Isacson, R.2
Haim, N.3
Gez, E.4
Sulkes, A.5
-
21
-
-
0031819260
-
Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia
-
DOI 10.1097/00000421-199808000-00006
-
Vadell C, Seguì MA, Gimènez-Arnau JM, Morales S, Cirera L, Bestit I et al. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Am J Clin Oncol 1998; 21 (4): 347-351. (Pubitemid 28366901)
-
(1998)
American Journal of Clinical Oncology: Cancer Clinical Trials
, vol.21
, Issue.4
, pp. 347-351
-
-
Vadell, C.1
Segui, M.A.2
Gimenez-Arnau, J.M.3
Morales, S.4
Cirera, L.5
Bestit, I.6
Batiste, E.7
Blanco, R.8
Jolis, L.9
Boleda, M.10
Anton, I.11
|